Discontinuation report ATORVASTATIN

Last updated on 2020-07-23 History
Report ID 120976
Drug Identification Number 02399385
Brand name ATORVASTATIN
Common or Proper name ATORVASTATIN
Company Name PHARMASCIENCE INC
Market Status MARKETED
Active Ingredient(s) ATORVASTATIN
Strength(s) 20MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 500
ATC code C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2020-07-22
Remaining supply date 2020-07-22
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments Transition to DIN 02477157
Health Canada comments
Contact Address 6111, ROYALMOUNT AVENUE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2020-07-23 French Compare
v1 2020-07-23 English Compare